Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05013229 |
|---|---|
| Brief Title: | A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3) |
| First Submitted : | August 13, 2021 |
| First Submitted that Met QC Criteria : | August 13, 2021 |
| First Posted : | August 19, 2021 |
| Last Update Submitted that Met QC Criteria : | February 21, 2024 |
| Last Update Posted : | February 23, 2024 |